Massachusetts General Hospital

Biography

Steven M. Greenberg MD, PhD, is the director of the Hemorrhagic Stroke Research Program at the Massachusetts General Hospital and Professor of Neurology at the Harvard Medical School. Initiated in 1994, the Hemorrhagic Stroke Research Program has become internationally recognized as a leading authority on the causes, diagnosis, and treatment of cerebral amyloid angiopathy. Dr. Greenberg has authored over 82 research articles and over 35 chapters, reviews, and editorials, served as Principal Investigator on multiple national research grants and in leadership positions at national and international conferences on hemorrhagic stroke and vascular cognitive impairment.

Dr. Greenberg received his undergraduate degree in biochemistry from Harvard University and his MD/PhD degrees from Columbia University.  He served his internship at the Pennsylvania Hospital, did his neurology residency at the Massachusetts General Hospital, and finished his post-doctoral fellowship at the Brigham and Women's Hospital.

Research

Dr. Greenberg is Director of the Hemorrhagic Stroke ResearchProgram at Massachusetts General Hospital and Professor of Neurology at HarvardMedical School.  Initiated in 1994,the Hemorrhagic Stroke Research Program has become internationally recognizedas a leading authority on the causes, diagnosis, and treatment of cerebralamyloid angiopathy.  Dr. Greenberghas authored over 80 research articles and over 40 chapters, reviews, andeditorials, served as principal investigator on multiple national researchgrants and in leadership positions at national and international conferences onhemorrhagic stroke and vascular cognitive impairment. 

Publications

View my most recent publications at PubMed

Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, van Buchem MA, Bruckmann H, Greenberg SM. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010;74:1346-1350.

Greenberg SM, Nandigam RNK, Delgado P, Betensky RA, Rosand J, Viswanathan A, Frosch MP, Smith EE. Microbleeds versus macrobleeds: Evidence for distinct entities. Stroke 2009;40:2382-6.

Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, Greenberg SM. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009;72:1230-1235.

Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CRG, Greenberg SM. Spatial distribution of white matter hyperintensities in Alzheimers disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008;39:1127-1133.

Greenberg SM, Grabowski TJ, Gurol ME, Skehan ME, Nandigam RNK, Becker JA, Garcia-Alloza M, Prada C, Frosch MP, Rosand J, Viswanathan A, Smith EE, Johnson KA. Detection of isolated cerebrovascular ?-amyloid with Pittsburgh compound B. Ann Neurol 2008;64:587-591.

Statin risks may outweigh benefits for patients with a history of brain hemorrhage

A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology.